DENTSPLY SIRONA Inc. XRAY Cash Flow

Dentsply sirona inc. (XRAY)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
Cash flows from operating activities:
Net (loss) income
-139,900	102,500	85,000	36,400	39,200	1,500	27,500	-1,121,000	81,100	-650,200	90,500	-1,050,300	59,700	107,900	92,300	105,900	125,300	58,600	84,500	44,000	64,000	84,700	75,266	90,014	72,920	76,071	80,865	88,691	72,573	127,928	54,292	82,041	54,228	41,393	61,200	75,390	69,463	67,984	63,814	73,346	62,191	76,050	67,853	70,579	59,930
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation
32,200	31,600	31,200	35,500	34,900	29,500	34,600	35,500	33,300	33,400	31,800	31,200	30,900	29,600	31,900	31,600	23,500	17,500	22,800	19,500	19,300	18,100	20,775	20,955	21,370	20,055	19,802	21,327	20,416	19,947	19,152	20,148	20,209	16,981	14,699	17,159	15,200	13,846	13,584	14,173	15,265	13,969	13,745	13,443	12,930
Amortization of intangible assets
47,200	46,700	47,400	47,300	48,200	48,200	49,600	50,200	49,900	48,600	48,700	46,600	45,200	45,200	44,300	43,800	21,800	11,000	11,000	10,900	10,900	11,500	11,907	11,924	12,569	11,600	11,266	11,499	11,935	12,454	9,275	12,654	15,360	4,166	12,094	2,357	2,379	1,947	2,326	2,247	2,524	1,416	2,653	3,133	3,441
Amortization of deferred financing costs
700	600	700	700	700	700	700	600	700	700	600	600	700	900	1,500	1,000	1,100	8,000	1,100	1,100	1,100	1,100	1,215	1,143	1,142	1,158	1,250	1,296	1,296	1,296	3,358	1,195	1,196	8,023	0	0	0	-	-	-	-	-	-	-	-
Goodwill impairment
156,600	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Indefinite-lived intangible asset impairment
38,700	0	0	0	5,300	0	0	179,200	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-8,100	2,500	-21,500	-12,400	-6,000	35,900	-27,100	-54,000	-16,800	-97,500	-12,100	-44,000	9,800	-8,100	-31,500	9,900	-80,400	-11,800	10,500	8,500	20,200	12,900	9,493	6,612	-11,505	2,896	-23,532	3,229	-11,793	-62,825	1,730	-8,122	3,690	-59,449	-35,847	5,674	1,220	5,279	9,897	3,688	-3,745	-9,460	5,276	6,129	-1,750
Stock based compensation expense
9,500	16,400	15,400	25,200	9,200	5,900	5,300	500	9,300	7,200	18,900	11,100	10,800	11,900	12,000	12,600	4,800	6,100	7,700	6,900	4,900	5,500	6,542	7,572	5,786	7,073	6,004	6,589	5,434	4,939	6,219	6,807	4,222	5,288	5,343	5,648	4,668	4,034	4,531	5,015	5,223	1,498	5,055	4,934	4,789
Restructuring and other costs - non-cash
1,900	900	400	5,100	9,700	3,300	10,100	5,800	3,300	53,100	10,600	400	600	5,500	900	700	2,600	5,500	-8,000	41,000	4,800	5,800	0	0	0	-	-	-	-	-	-	-	-	1,735	1,512	-787	0	16	0	0	363	-	-	-	-
Stock option income tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	1,400	2,500	400	8,400	1,600	1,200	8,400	400	1,700	51	280	69	138	1,140	519	603	1,808	6,038	1,284	3,879	-5,665	487	1,846	4,371	-121	118	2,768	1,898	-	-	-	-
Net interest expense on derivatives with an other than insignificant financing element
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,142	822	723	-	-	-	-	-	-	-	-
Equity in earnings from unconsolidated affiliates
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100	10,900	-8,300	-4,300	1,200	-943	-367	-290	780	-83	2,182	-1,779	2,178	-2,529	1,329	-4,248	661	1,597	917	-824	-	-	-	-	-	-	-	-
Other non-cash expense (income)
-8,100	7,900	-4,300	8,900	7,800	-5,400	-900	16,900	-14,000	-11,500	7,100	-19,900	14,400	-9,400	9,900	28,100	3,400	3,100	-3,600	5,600	8,000	-6,400	-12,710	5,705	3,405	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,322	0	0	328
Loss (gain) on disposal of property, plant and equipment
-200	-700	-2,300	-700	100	-1,900	-2,100	-100	-500	700	-1,900	-100	-300	-1,000	-1,300	-500	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on divestiture of noncontrolling interest
0	0	0	0	8,700	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on sale on non-strategic businesses and product lines
-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefits from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-918	-1,411	-592
Gain on sale of equity security
-	-	-	-	-	0	0	0	44,100	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-cash expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20,016	-	-5,252	-6,150	3,048	-	4,221	-2,037	1,082	-	-	-	-	-	-	-	-
Accounts and notes receivable-trade, net
-53,300	70,700	19,200	38,000	-36,500	1,600	-2,100	64,500	-87,500	5,800	59,500	44,300	-46,200	-17,800	10,100	15,700	67,100	-27,000	-12,100	29,800	10,200	-38,100	-605	8,585	22,920	-32,955	-6,869	34,687	37,637	-29,352	482	15,864	25,597	-28,474	-13,352	11,651	28,706	-21,883	-11,719	12,957	15,530	40,108	11,292	-14,713	-19,745
Inventories, net
57,300	-62,100	30,100	-13,200	31,500	-63,400	14,000	4,600	64,700	-4,400	17,700	11,300	38,300	-24,500	3,800	-36,100	-8,600	-22,000	-6,000	-11,500	7,400	-26,700	-16,727	7,247	15,180	-19,884	4,584	18,620	22,080	-17,537	7,295	13,028	34,006	-24,112	-5,759	-6,359	14,727	-11,490	11,688	-5,361	14,472	-38,380	8,379	20,966	-18,675
Prepaid expenses and other current assets, net
27,200	-16,600	11,500	-24,200	16,300	-20,200	21,600	20,100	5,600	14,800	900	50,100	9,200	9,700	14,200	-8,400	16,900	2,500	8,800	-7,400	5,600	3,700	6,332	317	5,751	-763	227	-15,726	-10,638	-8,672	4,343	-4,617	24,072	-7,083	6,089	-3,818	5,745	-2,600	-10,244	10,820	5,729	-7,244	-3,876	2,916	1,208
Other noncurrent assets, net
6,800	-5,900	21,300	-2,100	-4,800	2,400	2,600	4,800	2,900	8,000	-3,100	-15,600	14,400	2,300	-3,300	-4,000	2,400	800	-3,400	-3,200	2,500	-4,600	796	369	-1,465	2,092	-147	1,387	-2,232	-3,596	-754	19,451	-15,954	1,252	-4,211	5,642	-1,123	-	-	-	-	-	-	-	-
Accounts payable
-28,900	56,600	1,700	-20,900	-11,300	-3,000	16,600	-2,600	-3,900	35,100	-400	-13,900	23,400	8,600	-15,300	12,700	1,200	-2,400	6,300	-300	5,200	8,100	-8,713	2,566	8,047	-11,601	-13,956	-215	-10,928	24,400	-10,237	-12,848	11,528	6,148	539	-1,440	5,569	4,555	-14,993	3,408	9,195	4,752	1,558	-8,624	-2,633
Accrued liabilities
-95,100	80,800	45,600	9,000	-90,100	7,400	-2,500	72,800	-77,400	-18,500	66,000	16,800	-36,000	-14,700	13,600	4,400	-15,500	-9,300	22,300	18,600	-36,300	-19,800	13,828	15,673	-21,901	-4,906	2,757	6,507	-8,558	-10,464	12,732	17,942	-21,186	7,259	25,908	24,912	-15,861	-4,706	9,527	16,702	-12,519	-3,329	11,882	16,602	-26,863
Income taxes
7,000	-27,200	22,400	-23,300	12,300	-1,100	41,700	-14,400	-14,100	3,600	-8,700	16,000	-31,400	1,000	32,800	-40,400	-1,100	-900	-7,100	4,400	-4,500	-5,500	-7,632	12,109	23,423	-30,044	47,214	3,526	-21,196	4,303	12,379	-5,122	10,545	30,840	-17,643	1,426	11,516	-7,609	5,482	11,714	-6,801	8,650	9,332	-8,054	-1,824
Other noncurrent liabilities
-2,800	-6,800	2,800	1,500	300	-13,000	2,200	-10,700	5,000	1,900	-1,400	9,100	-1,400	-4,700	6,300	400	7,000	3,000	4,400	3,900	5,800	700	968	9,248	-1,716	6,305	795	3,538	2,562	-9,149	-2,205	19,131	-15,535	-2,723	6	2,536	371	8,806	-1,265	-4,815	-2,477	-	-	-	95
Net cash (used in) provided by operating activities
-10,700	299,300	159,100	145,100	29,300	202,200	125,600	116,900	55,100	228,900	164,300	126,200	82,500	222,400	152,900	187,400	700	126,400	159,800	145,600	65,600	192,700	147,455	155,680	64,565	159,534	126,398	95,782	36,086	167,620	98,670	83,442	19,953	138,637	88,323	121,781	44,728	121,403	105,590	113,924	36,544	117,125	130,005	104,720	10,639
Cash flows from investing activities:
Cash paid on sale of non-strategic businesses or product lines
0	-	-	-	-1,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liquidation of short term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	5	156	58
Capital expenditures
25,600	36,000	23,400	29,600	33,900	51,900	49,400	45,400	35,800	45,700	33,800	33,700	31,100	46,000	31,200	27,000	20,800	20,300	18,200	17,300	16,200	26,600	24,169	23,509	25,322	26,800	27,349	22,119	24,032	27,213	21,873	24,344	18,642	25,728	20,120	13,564	11,774	14,670	10,669	10,867	8,030	13,199	18,325	10,774	14,183
Cash paid on sale of business or product line
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash assumed in Sirona merger
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	522,300	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of company owned life insurance policies
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,700	0	1,400	0	0	-	-	-	-	-	-	-	-	0	0	0	1,577	0	0	0	0	-	-	-	-	-	-	-	-
Cash received on derivative contracts
9,400	5,800	7,500	4,300	22,700	4,300	1,800	1,900	0	0	1,200	2,900	2,400	7,400	2,000	5,000	5,700	8,300	8,100	5,700	8,600	62,300	3,226	810	864	1,628	1,673	7,499	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for acquisitions of businesses and equity investments, net of cash acquired
-	-	-	-	-	0	0	123,800	6,700	10,000	10,700	116,100	9,100	0	341,400	0	400	50,700	0	3,300	0	-	-	-	-	62,261	0	0	3,939	4,861	0	0	0	-10,403	1,777,832	14,505	5,582	13,559	13,688	622	7,687	0	0	2,412	574
Cash received on sale of non-strategic businesses or product lines
-	-	-	-	-	-	-	-	-	-	-	-	-	100	3,600	0	2,400	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of short-term investments
0	0	-300	-500	800	3,600	100	0	0	200	0	2,200	100	6,800	0	0	0	-	-	-	-	0	1,165	-9	1,144	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid on derivatives contracts
-	-	-	-	-	0	0	0	2,400	0	0	0	0	1,400	12,100	100	3,500	5,500	0	0	800	91,600	894	1,903	2,103	9,233	824	49,078	45,765	0	0	14,221	0	-	-	-	-	-	-	-	-	-	-	-	-
Expenditures for identifiable intangible assets
-	-	-	-	-	0	200	2,000	3,300	0	800	1,100	4,800	0	1,100	0	0	-	-	-	200	4,900	-16	11	1,305	51	86	758	205	3,133	8	42	146	2,731	5	78	254	1,315	36	148	107	-114	-1,130	1,258	0
Proceeds from sale of property, plant, and equipment, net
700	500	3,600	400	300	2,900	2,400	900	3,000	5,300	200	300	1,600	100	500	4,000	400	100	0	200	100	0	323	109	168	-92	883	991	1,218	486	88	299	166	-96	418	123	52	3,053	230	166	113	3,717	1,145	981	17
Net cash used in investing activities
-15,500	-28,700	-15,200	-11,800	-12,700	-48,300	-45,500	-114,300	-45,200	-50,600	-43,900	-150,800	-41,100	-46,600	-379,700	-18,100	504,400	-68,100	36,200	-14,500	-8,500	-62,300	-21,054	-26,504	-28,842	-98,309	-25,703	-63,465	-72,723	-34,721	-21,793	-38,308	-20,199	-41,259	-1,800,001	-28,024	-17,558	-94,554	-42,732	-11,471	-15,711	-9,365	-16,045	-13,307	-14,682
Cash flows from financing activities:
Proceeds (repayments) on short-term borrowings, net
30,800	-1,100	-44,100	44,600	-67,900	-63,900	-63,000	195,100	-7,800	8,800	0	100	1,300	3,600	-44,100	-1,500	-2,100	-3,100	-32,500	-126,700	160,100	-2,100	-61,713	-102,973	64,886	48,511	-31,661	24,317	16,133	-113,444	-80,287	-46,336	11,155	269,796	590	-3,580	3,403	710	-5,130	-3,113	-2,124	-5,983	-37,824	35,297	1,045
Excess tax benefits from stock based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	1,400	2,500	400	8,400	1,600	1,200	8,400	400	1,700	51	280	69	138	1,140	519	603	1,808	6,038	1,284	3,879	-5,665	487	1,846	4,371	-121	118	2,768	1,898	584	918	1,411	592
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100	-100	0	80,500	0	-33	0	33	40	0	0	8,960	-	0	0	0	-343	0	886	15,545	-	-	-	-	-	-	-	-
Cash paid for treasury stock
140,000	100,000	100,000	60,000	0	-	-	-	-	250,000	-100	73,600	77,900	119,200	94,700	171,200	428,800	0	13,700	14,000	85,000	92,400	16,214	14,191	40,395	45,619	10,103	62,278	0	-2	-1	7,971	30,869	0	0	5,821	73,679	15,458	31,905	135,207	41,423	57,465	11,475	5,114	4,664
Cash dividends paid
22,100	22,200	19,600	19,600	19,500	19,500	19,400	19,900	19,800	20,100	20,100	20,100	18,000	17,900	18,100	18,500	10,100	10,100	10,300	10,100	9,500	9,400	9,447	9,474	8,979	8,905	8,967	9,019	7,909	7,864	7,855	7,859	7,847	7,120	7,200	7,181	7,131	6,025	7,311	8,332	7,409	7,453	7,464	7,459	7,460
Proceeds from long-term borrowings, net of deferred financing costs
0	0	117,200	800	900	-200	0	200	100	200	0	-100	3,000	379,900	760,800	0	79,900	152,900	0	0	0	-	-	-	-	-	-	-	-	-	-	-	4,571	-339,900	1,408,160	-12,846	51,100	4,911	113,700	-61,834	311,834	-	-	-	108,900
Repayments on long-term borrowings
800	0	116,600	132,700	1,900	100	8,900	200	200	500	9,600	1,200	5,400	374,300	375,700	0	127,500	158,400	8,900	100	100,100	200	123,629	197	75,174	-	-	-	0	-	-	-	5,171	596	248,933	452	1,951	1,752	277	-59,107	299,215	1,253	2,010	1,633	53,507
Proceeds from exercised stock options
3,800	30,000	2,400	56,600	19,800	5,100	8,900	5,600	8,300	29,400	7,500	16,000	29,400	14,200	6,400	13,000	7,400	8,300	8,600	4,500	14,100	30,300	5,964	8,587	4,149	18,550	17,137	17,635	13,578	9,353	4,764	5,583	14,483	5,982	2,300	11,822	22,171	3,257	1,087	18,442	7,403	3,955	3,601	4,490	1,360
Cash paid for contingent consideration on prior acquisitions
1,600	2,500	100	0	30,600	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	738	0	1,781	1,243	0	1,780	0	-	-	-	-	-	-	-	-
Proceeds from Derivative Instrument, Financing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	-439	464	-	-	-	613	-	-	-	-	-	-	-	-	-	-	-	-
Payments for Derivative Instrument, Financing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49	-226	306	-	-	-	1,413	-	1,142	822	723	-	-	-	-	-	-	-	-
Net cash used in financing activities
-129,900	-95,800	-160,800	-110,300	-99,200	-78,600	-82,400	-69,400	-19,400	-232,200	-22,100	-78,900	-67,600	-112,700	237,100	-177,800	-472,800	-8,900	-55,500	-138,000	-100,500	-71,900	-90,855	-117,968	-55,477	-37,050	-109,214	-29,039	13,603	-110,024	-78,171	-55,034	-12,380	-79,569	1,119,634	-19,700	-17,984	-16,113	70,282	-128,169	-29,036	18,476	-54,254	-81,908	46,266
Effect of exchange rate changes on cash and cash equivalents
-12,900	4,000	-7,100	1,700	-1,600	1,200	-3,900	-11,000	6,000	4,500	3,300	8,600	5,600	-9,900	8,800	-3,000	6,200	-1,200	-600	2,800	-7,600	-4,600	-4,821	-102	623	199	2,150	-2,454	-895	1,182	4,159	-4,236	2,844	-22,547	2,200	22,389	26,040	-4,941	60,756	-38,954	-37,128	-9,256	21,791	16,067	-19,915
Net decrease in cash and cash equivalents
-169,000	178,800	-24,000	24,700	-84,200	76,500	-6,200	-77,800	-3,500	-49,400	101,600	-94,900	-20,600	53,200	19,100	-11,500	38,500	48,200	139,900	-4,100	-51,000	53,900	30,725	11,106	-19,131	24,374	-6,369	824	-23,929	24,057	2,865	-14,136	-9,782	-4,738	-589,844	96,446	35,226	5,795	193,896	-64,670	-45,331	116,980	81,497	25,572	22,308
Non-cash investing activities:
Merger financed by common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	6,256,200	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-